Search - tctmd.com

Displaying 941 - 960 of 1431

Sort: Relevancy | Date

News Conference News EuroPCR 2017

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Yael L. Maxwell

May 17, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Daily News

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

Caitlin E. Cox

May 08, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

A Grain of Salt: Framingham Offspring Data Refute Dietary Sodium Guidelines

L.A. McKeown

April 25, 2017

News Daily News

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Yael L. Maxwell

April 18, 2017

News Daily News

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

Shelley Wood

April 12, 2017

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

News Daily News

Time to Centralize Care for Out-of-Hospital Cardiac Arrest?

Alison Palkhivala

April 10, 2017

News Daily News

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Yael L. Maxwell

April 04, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Conference News ACC 2017

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

Michael O'Riordan

March 24, 2017

News Conference News ACC 2017

RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest

Yael L. Maxwell

March 20, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

Shelley Wood

March 18, 2017

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

L.A. McKeown

March 18, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

News Daily News

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

L.A. McKeown

March 02, 2017

Advertisement

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

TCTMD’s Top 10 Most Popular Stories for April 2017

A Grain of Salt: Framingham Offspring Data Refute Dietary Sodium Guidelines

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Time to Centralize Care for Out-of-Hospital Cardiac Arrest?

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Live From Washington: ACC 2017, Day Three

Live From Washington: ACC 2017, Day Two

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content